TSE:4967 - Kobayashi Pharmaceutical Co Ltd Kobayashi Pharmaceutical Co Lt
Sector: Consumer Staples, Industry: Personal Products
Add to Watchlist
   
Add Alert 


Yahoo Finance
Quarterly TTM
Balance Sheet Cash Flow Income Statement Key Ratios
Adjust Display Metrics

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2016 2017 2018 2019 2020 Graph
Total Assets [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 228.79B
4.5%
233.73B
2.2%
238.37B
2.0%
Total Liabilities [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 62.54B
-3.8%
61.08B
-2.3%
55.78B
-8.7%
Total Equity [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 166.25B
8.1%
172.66B
3.9%
182.58B
5.7%
Operating CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 20.01B
-10.5%
20.09B
0.4%
23.99B
19.4%
Investing CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -8.06B
-
-5.07B
-
-12.66B
-
Financing CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -4.29B
-
-14.58B
-
-6.02B
-
Beginning Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 48.69B
71.9%
55.92B
14.8%
56.27B
0.6%
End Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 55.92B
14.8%
56.27B
0.6%
61.16B
8.7%
Free CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 16.31B
-14.8%
15.29B
-6.3%
19.84B
29.8%
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 167.48B
6.8%
158.34B
-5.5%
150.51B
-4.9%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 25.3B
12.1%
26.8B
5.9%
26.64B
-0.6%
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 18.02B
13.6%
19.14B
6.2%
19.2B
0.3%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 227.95
13.4%
244.08
7.1%
245.71
0.7%
Net Margin [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 10.76%
6.3%
12.09%
12.3%
12.76%
5.6%
Return On Equity [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 11.26%
5.5%
11.29%
0.3%
10.81%
-4.3%
Return On Assets [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 8.05%
6.6%
8.28%
2.8%
8.14%
-1.7%
Values are in JPY whenever applicable | Fiscal year ends on December 31
Powered by Morningstar